FindTrial
Sign In

A multicenter retrospective study comparing the safety outcomes of the reverse-sequence endoscopic nipple-sparing matectomy and the conventional open breast surgery (RECBS-01)

A multicenter retrospective study comparing the safety outcomes of the reverse-sequence endoscopic nipple-sparing matectomy and the conventional open breast surgery (RECBS-01) - RECBS-01

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300075286
Enrollment
Unknown
Registered
2023-08-31
Start date
2023-09-01
Completion date
Unknown
Last updated
2023-09-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast disease

Interventions

R-E-NSM (reverse-sequence endoscopic nipple-sparing mastectomy ):NA
C-O-BS (conventional open breast surgery):NA

Sponsors

West China Hospital, Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
15 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients who underwent reverse-sequence endoscopic nipple-sparing mastectomy and conventional open surgery at each center between May 2020 and April 2023

Exclusion criteria

Exclusion criteria: ?1 .Stage IV breast cancer ?2 .Patients with huge skin defect in the lesion area after tumor resection that needs skin grafts

Design outcomes

Primary

MeasureTime frame
local recurrence(LR);—

Secondary

MeasureTime frame
regional recurrence;overall survival(OS);breast cancer-specific survival(BCSS); disease-free survival (DFS);distant recurrence free survival (DDFS);long-term cosmetic complications;short-term surgical complications;Ueda scores;Ueda scores;—

Countries

China

Contacts

Public ContactZhenggui Du

West China hospital, Sichuan University

docduzg@163.com+86 189 8060 5774

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026